Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05250102 · ClinicalTrials.gov registry record · NA
Neonatal Pulse Oximetry Sensor Study
A NA study, sponsored by Medline Industries.
- Completed
- Registry status
- NA
- Development phase
- 23
- Enrollment target
NCT05250102 is a NA study that has completed, run by Medline Industries. The registered enrollment target is 23 participants.
The verdict
NCT05250102, a NA study, has completed, sponsored by Medline Industries.
- COMPLETED
- Registry status
- NA
- Development phase
- 23 participants
- Enrollment target
Study Summary
To validate the SpO2 accuracy, bias, and precision of Medline's reprocessed pulse oximetry sensors as compared to SaO2 in arterial blood samples as assessed by CO-oximetry in neonates.
Interventions
- DEVICE Pulse oximeter sensors
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 23 participants |
| Start Date | 2022-06-13 |
| Est. Completion | 2023-10-10 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05250102
The ClinicalTrials.gov registry entry for NCT05250102 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 23 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medline Industries, which has 24 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Pulse oximeter sensors is the first listed.
NCT05250102 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05250102 about?
NCT05250102 is a clinical study titled "Neonatal Pulse Oximetry Sensor Study". To validate the SpO2 accuracy, bias, and precision of Medline's reprocessed pulse oximetry sensors as compared to SaO2 in arterial blood samples as assessed by CO-oximetry in neonates.
What is the current status of trial NCT05250102?
This trial is currently completed. It is a NA study. The enrollment target is 23 participants. The study started on 2022-06-13. Estimated completion is 2023-10-10.
What interventions are being tested in trial NCT05250102?
The interventions under investigation include: Pulse oximeter sensors (DEVICE).
Who is sponsoring clinical trial NCT05250102?
This trial is sponsored by Medline Industries, which has 24 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.